Pharmacology of drugs in extrapyramidal disorders D.r Datten Bangun,MSc,SpFK Dr.Sake Juli Martina,SpFK Dept.Farmakologi & Therapeutik Fak.Kedokteran,USU MEDAN Extrapyramidal…

Department of Chemistry Umeå University S-901 87 Umeå, Sweden Degree thesis in Chemistry 15 ECTS-credits Swedish Master’s level 2006 Autoimmunity against alpha synuclein…

beclomethasone synthetic glucocorticoid that readily penetrates the airway mucosa, used for asthma thioridazine low potency dopamine receptor blocker thioridazine side effects…

1.365REVIEWMultiple actions of the chemokine stromal cell-derived factor-1a on neuronal activity Alice Guyon and Jean-Louis Nahon ´ CNRS UMR 6097, Institut de Pharmacologie…

1.PARKINSON’S DISEASE Sankar Alagapan Nov 23 2009 From A Manual of Diseases of the Nervous System: William Gowers2. OVERVIEWIntroductionDisease Symptoms and MechanismsPathophysioloMolecularSymptoms…

1.BLOOD andHEMOPOIESISAssoc. Prof. Dr. Karim Al-JashamyIMS/MSU 2010 2. Formed Elements of Blood• Erythrocytes (RBC) • Leukocytes (WBC) – Granulocytes – Agranulocytes…

1.A SEMINAR ONTHE PHYSIOLOGY OF DRUG ADDICTIONBY, DAWN V TOMY. (M.PHARM) RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR COIMBATORE12. INTRODUCTION TO DRUGSWHO DEFINITION “A…

1. PARKINSON’S DISEASE Pharmacotherapeutics III By Sohel Memon (Doctor of Pharmacy) 2. TOPICS TO BE DISCUSSED 1.Definition2.Epidemiology3.Etiology4.Risk factor5.Types6.Signs…

1. - a neurological syndrome. 2. EPIDEMILOGY   In India there is a low prevalence of Parkinson’s disease. We find it in Parsi community of Mumbai. Even though…

1. Reticular Activating System 2. Organization of Reticular Neurons 3. General Characteristics of RAS 4. Noradrenergic and adrenergic neurons in the medulla and pons 5. Noradrenergic…